MGMengzheng Guo

Mengzheng Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mengzheng Guo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Dexian Zhi

    Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China

    1 shared publication
  • Hui Zhao

    State Experimental and Training Centre of Food and Drug School of Biotechnology and Food Science Tianjin Key Laboratory of Food and Biotechnology Tianjin University of Commerce 300134 Tianjin China

    1 shared publication
  • Liang Bai

    Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China

    1 shared publication
  • Lianying Fang

    Institute of Radiation Medicine, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China

    1 shared publication
  • Liwen Wang

    College of Food Science and Technology, Hebei Agricultural University, Baoding 071000, China

    1 shared publication
  • Qiang Liu

    Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

    1 shared publication

Latest Publications

  • Open Access

    Dietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF-κB Signaling

    by Liwen Wang, Zhiwei Yue, Mengzheng Guo, Lianying Fang, Liang Bai, Xinyu Li, Yongqing Tao, Suying Wang, Qiang Liu, Dexian Zhi, et al.

    Hyperoside, an active compound found in plants of the generaHypericumandCrataegus, is reported to exhibit antioxidant, anticancer, and anti-inflammatory activities. Induction of hepatic stellate cell (HSC) apoptosis is recognized as a promising strategy for attenuation of hepatic fibrosis. In this study, we investigated whether hyperoside treatment can exert antifibrotic effects in human LX-2 hepatic stellate cells. We found that hyperoside induced apoptosis in LX-2 cells and decreased levels ofα-smooth muscle actin (α-SMA), type I collagen, and intracellular reactive oxygen species (ROS). Remarkably, hyperoside also inhibited the DNA-binding activity of the transcription factor NF-κB and altered expression levels of NF-κB-regulated genes related to apoptosis, including proapoptotic genesBcl-Xs,DR4,Fas, andFasLand anti-apoptotic genesA20,c-IAP1,Bcl-XL, andRIP1. Our results suggest that hyperoside may have potential as a therapeutic agent for the treatment of liver fibrosis.